Luminex Buys Nanosphere, Citing Infectious Disease Strength
This article was originally published in Clinica
Executive Summary
Diagnostics platform and assay-maker Luminex has agreed to buy molecular diagnostics specialists Nanosphere for a total cash outlay of $72m, the companies announced May 16.